Oncology

Chapters

Transcript

Video

Omar Nadeem, MD discusses results of the Phase II d-PRISM study

Daratumumab in high-rish MGUS and low-risk smoldering myeloma

Related Presenters

Omar Nadeem, MD.

Omar Nadeem, MD

Medical Oncology

View Full profile

ADVERTISEMENT

Related Videos

Reid W. Merryman, MD discusses results of a multicenter phase II trial Video

Reid W. Merryman, MD discusses results of a multicenter phase II trial

Jacqueline Garcia, MD discussed results from the Phase # VERONA study Video

Jacqueline Garcia, MD discussed results from the Phase # VERONA study

Jennifer Brown, MD, PhD discusses results form the ALPINE trial Video

Jennifer Brown, MD, PhD discusses results form the ALPINE trial

Austin Kim, MD discusses phase I/II study Video

Austin Kim, MD discusses phase I/II study

Jorge J. Castillo, MD discusses results from a multicenter phase 2 Study Video

Jorge J. Castillo, MD discusses results from a multicenter phase 2 Study

Marlise Luskin, MD, MSCE discusses results of a phase 1 trial Video

Marlise Luskin, MD, MSCE discusses results of a phase 1 trial